NovaBridge Biosciences — insider transactions
7 transactions on record · NBP · CIK 1778016
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
7
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$5.8K
Median disclosure lag
5.0 d
trade date to filing date
Largest single trade, 24m
$5.8K
2026-09-18
Director share, 12m
0.0%
of transactions where role is stated
Current run
7 sells
consecutive same-direction transactions
Net 3m flow
-$5.8K
purchases minus sales
Total on record
7
Transactions
7 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 | 2026-09-17 | 4 | Dennis Phillip Andrew | Chief Medical Officer | Exercise of derivative | 23,695 | — | — | filing |
| 2026-09-21 | 2026-09-18 | 3 | Dennis Phillip Andrew | Chief Medical Officer | Open market sale | 8,209 | $0.71 | $5.8K | filing |
| 2026-09-21 | 2026-09-17 | 4 | Dennis Phillip Andrew | Chief Medical Officer | Exercise of derivative | 10,302 | $0.00 | — | filing |
| 2026-09-08 | 2026-09-03 | 5 | Cao Sean Wuxiong | Chief Bus. Development Officer | Exercise of derivative | 235,136 | — | — | filing |
| 2026-09-08 | 2026-09-03 | 5 | Cao Sean Wuxiong | Chief Bus. Development Officer | Exercise of derivative | 45,320 | $0.00 | — | filing |
| 2026-09-08 | 2026-09-03 | 5 | Cao Sean Wuxiong | Chief Bus. Development Officer | Exercise of derivative | 102,233 | $0.00 | — | filing |
| 2026-09-08 | 2026-09-03 | 5 | Cao Sean Wuxiong | Chief Bus. Development Officer | Exercise of derivative | 104,236 | — | — | filing |